Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Differentiated thyroid cancer: prognostic factors].

G Conzo1, A Giordano, C Caracò

  • 1Istituto di Semeiotica Chirurgica, Facoltà di Medicina e Chirurgia, II Università degli Studi di Napoli.

Il Giornale Di Chirurgia
|April 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.

European review for medical and pharmacological sciences·2017
Same author

Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.

Journal of cellular physiology·2016
Same author

Measurement of volatile organic compounds (VOCs) in libraries and archives in Florence (Italy).

The Science of the total environment·2016
Same author

Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.

Current research in translational medicine·2016
Same author

Oxidative stress in IgA nephropathy.

Nephron. Clinical practice·2010
Same author

[News on the etiopathogenesis and the treatment of Schoenlein-Henoch nephritis].

Minerva pediatrica·2009

Total thyroidectomy is the gold standard for differentiated thyroid cancer treatment. Age, metastasis (M+), and follicular histotype are key prognostic factors identifying high-risk patients needing aggressive therapy.

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Nuclear Medicine

Context:

  • Analysis of 152 differentiated thyroid cancer patients undergoing thyroidectomy between 1978-1996.
  • Evaluation of prognostic factors influencing treatment outcomes.
  • Established surgical techniques and diagnostic protocols in thyroid cancer management.

Purpose:

  • To identify independent prognostic factors for differentiated thyroid cancer.
  • To determine criteria for classifying high-risk patients.
  • To guide therapeutic approaches based on patient-specific risk factors.

Summary:

  • Total thyroidectomy is confirmed as the gold standard, enabling radioactive iodine (131I) therapy.
  • Modified radical neck dissection (MRND) is routinely performed for N+ cases, reserved for high-risk patients.

Related Experiment Videos

  • Age, M+ status, and follicular histotype are significant prognostic factors, classifying patients requiring aggressive treatment.

    • Impact:

    • Provides evidence for risk stratification in differentiated thyroid cancer.
    • Informs clinical decision-making for personalized treatment strategies.
    • Highlights the importance of age and specific histopathological features in predicting outcomes.